NCT04280081 2025-04-20LIBRETTO-321Eli Lilly and CompanyPhase 2 Active not recruiting77 enrolled 13 charts
NCT01856920 2024-07-09QUILT-3.006 for Recurrent Medullary Thyroid CancerNantCell, Inc.Phase 2 Completed35 enrolled 9 charts
NCT04787328 2022-02-23A Study of HA121-28 Tablets in Patients With Medullary Thyroid Carcinoma (MTC)CSPC ZhongQi Pharmaceutical Technology Co., Ltd.Phase 2 Unknown30 enrolled
NCT02114658 2017-08-03Sorafenib Phase II Study for Japanese Anaplastic or Medullary Thyroid Carcinoma PatientsBayerPhase 2 Completed18 enrolled
NCT00358956 2017-01-30A Study To Assess ZD6474 (ZACTIMAâ„¢) Monotherapy In Locally Advanced or Metastatic Hereditary Medullary Thyroid CancerSanofiPhase 2 Completed19 enrolled 10 charts
NCT00096083 2013-10-23Hepatic Arterial Infusion of Melphalan With Hepatic Perfusion in Treating Patients With Unresectable Liver CancerDelcath Systems Inc.Phase 2 Completed56 enrolled
NCT00121628 2013-10-09A Phase 2, Open-label Study of AMG 706 to Treat Subjects With Locally Advanced or Metastatic Thyroid CancerAmgenPhase 2 Completed184 enrolled